Evidence map›Paper›PMID 36139722›Full record

ArticleAntioxidants (Basel, Switzerland)2022

NRF2 Mediates Cellular Resistance to Transformation, Radiation, and Inflammation in Mice.

Dörthe Schaue, Ewa D Micewicz, Josephine A Ratikan, Keisuke S Iwamoto, Erina Vlashi, J Tyson McDonald, William H McBride

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Dörthe SchaueDepartment of Radiation Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA 90095-1714, USA.ORCID 0000-0002-5674-678X
Ewa D MicewiczBiotts S.A., Ul. Wrocławska 44C, 55-040 Bielany Wrocławskie, Poland.
Josephine A RatikanDepartment of Radiation Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA 90095-1714, USA.
Keisuke S IwamotoDepartment of Radiation Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA 90095-1714, USA.
Erina VlashiDepartment of Radiation Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA 90095-1714, USA.
J Tyson McDonaldDepartment of Radiation Medicine, School of Medicine, Georgetown University, Washington, DC 20057, USA.
William H McBrideDepartment of Radiation Oncology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA 90095-1714, USA.ORCID 0000-0001-5008-3180
University of California, Los Angeles · USGeorgetown University · US

Funding

Women's CancersP30CA016042 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Robert Damoiseaux · 1985 to 2026
$134.5M
UCLA Center for Biological RadioprotectorsU19AI067769 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CHUTE, JOHN P, MCBRIDE, WILLIAM H. · 2005 to 2019
$44.6M
Drivers of Metabolic Plasticity Promote Radiation Resistance in Glioblastoma MultiformeR01CA251872 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI VLASHI, ERINA · 2020 to 2024
$2.8M
Acute radiation injury alters microRNA profiles that predict late tissue-specific damageU01AI148322 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SCHAUE, DORTHE · 2020 to 2024
$2.4M
Exploiting multidrug resistance mechanisms to counter radiation toxicityR01AI128739 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI IWAMOTO, KEISUKE S. · 2017 to 2021
$2.0M
Myeloid reprogramming in response to acute radiation tissue damageR01CA226875 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SCHAUE, DORTHE · 2019 to 2023
$1.8M
NCI NIH HHS P30 CA016042NCI NIH HHS R01 CA226875NCI NIH HHS R01 CA251872NIAID NIH HHS R01 AI128739NIAID NIH HHS U01 AI148322NIAID NIH HHS U19 AI067769
6 · The paper itself

Abstract

Nuclear factor erythroid 2-related factor 2 (NRF2) is recognized as a master transcription factor that regulates expression of numerous detoxifying and antioxidant cytoprotective genes. In fact, models of NRF2 deficiency indicate roles not only in redox regulation, but also in metabolism, inflammatory/autoimmune disease, cancer, and radioresistancy. Since ionizing radiation (IR) generates reactive oxygen species (ROS), it is not surprising it activates NRF2 pathways. However, unexpectedly, activation is often delayed for many days after the initial ROS burst. Here, we demonstrate that, as assayed by γ-H2AX staining, rapid DNA double strand break (DSB) formation by IR in primary mouse

Indexed as

immune polarizationionizing radiationNF-κBNrf2

Identifiers

PMID36139722
PMCPMC9495793
OpenAlexW4293106302

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.